Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation

Resuscitation

Volumn 76, Issue 1, 2008, Pages 108-119

  Sharma, Arti B ^a   Barlow, Matthew A ^a   Yang, Shao Hua ^a   Simpkins, James W ^a   Mallet, Robert T ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Brain ischemia; Cardiac arrest; Cardiopulmonary resuscitation (CPR); Cerebral blood flow; Inflammatory response; Metabolism; Neurological dysfunction; Post resuscitation period

Indexed keywords

CASPASE 3; DNA FRAGMENT; MATRIX METALLOPROTEINASE; PYRUVIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; CARDIOPULMONARY ARREST; CELL DEATH; CONTROLLED STUDY; DEFIBRILLATION; DISEASE MODEL; DOG; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPUS; INFLAMMATION; METABOLIC DISORDER; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RESUSCITATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BRAIN; CARDIOPULMONARY RESUSCITATION; CASPASE 3; CEREBROVASCULAR CIRCULATION; DINOPROST; DOGS; ENERGY METABOLISM; HEART ARREST; IN SITU NICK-END LABELING; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; PEROXIDASE; PYRUVIC ACID; REGIONAL BLOOD FLOW;

EID: 36849086430     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2007.04.028     Document Type: Article

References (61)

1. Rosen H., Sunnerhagen K.S., Herlitz J., Blomstrand C., and Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 49 (2001) 183-191
2. Lundgren-Nilsson A., Rosen H., Hofgren C., and Sunnerhagen K.S. The first year after successful cardiac resuscitation: function, activity, participation and quality of life. Resuscitation 66 (2005) 285-289
3. Liu X.L., Wiklund L., Nozari A., Rubertsson S., and Basu S. Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigs. Acta Anaesthesiol Scand 47 (2003) 958-967
4. Mussack T., Biberthaler P., Kanz K.G., Wiedemann E., Gippner-Steppert C., and Jochum M. S-100b, sE-selectin, and sP-selectin for evaluation of hypoxic brain damage in patients after cardiopulmonary resuscitation: pilot study. World J Surg 25 (2001) 539-544
5. Bottiger B.W., Motsch J., Braun V., Martin E., and Kirschfink M. Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans. Crit Care Med 30 (2002) 2473-2480
6. Li Z.P., Chen S.Q., Wang S.S., et al. Expression of mRNA of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase after cardiopulmonary resuscitation for asphyxial cardiac arrest in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 17 (2005) 548-551
7. Zhao Z.Q., Velez D.A., Wang N.P., et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 6 (2001) 279-290
8. Love S. Apoptosis and brain ischaemia. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 267-282
9. Sato M., Hashimoto H., and Kosaka F. Histological changes of neuronal damage in vegetative dogs induced by 18 minutes of complete global brain ischemia: two-phase damage of Purkinje cells and hippocampal CA1 pyramidal cells. Acta Neuropathol 80 (1990) 527-534
10. Radovsky A., Safar P., Sterz F., Leonov Y., Reich H., and Kuboyama K. Regional prevalence and distribution of ischemic neurons in dog brains 96 h after cardiac arrest of 0-20 min. Stroke 26 (1995) 2127-2133
11. Bottiger B.W., Schmitz B., Wiessner C., Vogel P., and Hossmann K.A. Neuronal stress response and neuronal cell damage after cardiocirculatory arrest in rats. J Cereb Blood Flow Metab 10 (1998) 1077-1087
12. Linnik M.D., Zobrist R.H., and Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24 (1993) 2002-2008
13. Mallet R.T., Sun J., Knott E.M., Sharma A.B., and Olivencia-Yurvati A.H. Metabolic cardioprotection by pyruvate: recent progress. Exp Biol Med 230 (2005) 435-443
14. Miller L.P., and Oldendorf W.H. Regional kinetic constants for blood-brain barrier pyruvic acid transport in conscious rats by the monocarboxylic acid carrier. J Neurochem 46 (1986) 1412-1416
15. Gonzalez S.V., Nguyen N.H., Rise F., and Hassel B. Brain metabolism of exogenous pyruvate. J Neurochem 95 (2005) 284-293
16. Zhou F.Q. Pyruvate in the correction of intracellular acidosis: a metabolic basis as a novel superior buffer. Am J Nephrol 25 (2005) 55-63
17. Sharma A.B., Knott E.M., Bi J., Martinez R.R., Sun J., and Mallet R.T. Pyruvate improves cardiac electromechanical and metabolic recovery from cardiopulmonary arrest and resuscitation. Resuscitation 66 (2005) 71-81
18. Kim J.B., Yu Y.M., Kim S.W., and Lee J.K. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 1060 (2005) 188-192
19. Kawahara M., Kato-Negishi M., and Kuroda Y. Pyruvate blocks zinc-induced neurotoxicity in immortalized hypothalamic neurons. Cell Mol Neurobiol 22 (2002) 87-93
20. Nakamichi N., Kambe Y., Oikawa H., et al. Protection by exogenous pyruvate through a mechanism related to monocarboxylate transporters against cell death induced by hydrogen peroxide in cultured rat cortical neurons. J Neurochem 93 (2005) 84-93
21. Wang X., Perez E., Liu R., Yan L.-J., Mallet R.T., and Yang S.-H. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res 1132 (2007) 1-9
22. Suh S.W., Aoyama K., Matsumori Y., Liu J., and Swanson R.A. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54 (2005) 1452-1458
23. Lee J.Y., Kim Y.H., and Koh J.Y. Protection by pyruvate against transient forebrain ischemia in rats. J Neurosci 21 (2001) RC171(1-6)
24. Mongan P.D., Capacchione J., Fontana J.L., West S., and Bunger R. Pyruvate improves cerebral metabolism during hemorrhagic shock. Am J Physiol Heart Circ Physiol 281 (2001) H854-H864
25. Idris A.H., Becker L.B., Ornato J.P., and Hedges J.R. Utstein-style guidelines for uniform reporting of laboratory CPR research. Resuscitation 33 (1996) 69-84
26. Knott E.M., Sun J., Lei Y., Ryou M.G., Olivencia-Yurvati A.H., and Mallet R.T. Pyruvate mitigates oxidative stress during reperfusion of cardioplegia-arrested myocardium. Ann Thorac Surg 81 (2006) 928-934
27. Sharma A.B., Sun J., Howard L.L., Williams Jr. A.G., and Mallet R.T. Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrest. Am J Physiol Heart Circ Physiol 292 (2007) H198-H206
28. Bircher N., and Safar P. Cerebral preservation during cardiopulmonary resuscitation. Crit Care Med 13 (1985) 185-190
29. Benson D.M., O'Neil B., Kakish E., et al. Open-chest CPR improves survival and neurologic outcome following cardiac arrest. Resuscitation 64 (2005) 209-217
30. Wen Y., Perez E.J., Green P.S., Sarkar S.N., and Simpkins J.W. nNOS is involved in estrogen mediated neuroprotection in neuroblastoma cells. Neuroreport 15 (2004) 1515-1518
31. Barone F.C., Hillegass L.M., Price W.J., et al., White R.F. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 29 (1991) 336-345
32. Koh S.H., Chang D.I., Kim H.T., et al. Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. Toxicology 214 (2005) 131-139
33. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
34. Beekman B., Drijfhout J.W., Bloemhoff W., Ronday H.K., Tak P.P., and te Koppele J.M. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett 390 (1996) 221-225
35. Liu R., Wen Y., Perez E., et al. 17β-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res 1060 (2005) 55-61
36. Kofler J., Hurn P.D., and Traystman R.J. SOD1 overexpression and female sex exhibit region-specific neuroprotection after global cerebral ischemia due to cardiac arrest. J Cereb Blood Flow Metab 25 (2005) 1130-1137
37. Bottiger B.W., Teschendorf P., Krumnikl J.J., et al. Global cerebral ischemia due to cardiocirculatory arrest in mice causes neuronal degeneration and early induction of transcription factor genes in the hippocampus. Brain Res Mol Brain Res 65 (1999) 135-142
38. Chopp M., Li Y., Jiang N., Zhang R.L., and Prostak J. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 16 (1996) 578-584
39. Zong P., Setty S., Sun W., et al. Intermittent hypoxic training protects canine myocardium from infarction. Exp Biol Med 229 (2004) 806-812
40. Landis J.R., and Koch G.G. The measurement observer agreement for categorical data. Biometrics 33 (1977) 159-174
41. Pierre K., and Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94 (2005) 1-14
42. Raval A.P., Dave K.R., Prado R., et al. Protein kinase C delta cleavage initiates an aberrant signal transduction pathway after cardiac arrest and oxygen glucose deprivation. J Cereb Blood Flow Metab 25 (2005) 730-741
43. Chen J., Nagayama T., Jin K., et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 18 (1998) 4914-4928
44. Liu Y., Rosenthal R.E., Haywood Y., Miljkovic-Lolic M., Vanderhoek J.Y., and Fiskum G. Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome. Stroke 29 (1998) 1679-1686
45. Ryu J.K., Choi H.B., and McLarnon J.G. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease. Neuroscience 141 (2006) 1835-1848
46. Yu Y.M., Kim J.B., Lee K.W., Kim S.Y., Han P.L., and Lee J.K. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 36 (2005) 2238-2243
47. Mallet R.T., Squires J.E., Bhatia S., and Sun J. Pyruvate restores contractile function and antioxidant defenses of hydrogen peroxide-challenged myocardium. J Mol Cell Cardiol 34 (2002) 1173-1184
48. Xu K., Puchowicz M.A., Lust W.D., and LaManna J.C. Adenosine treatment delays postischemic hippocampal CA1 loss after cardiac arrest and resuscitation in rats. Brain Res 1071 (2006) 208-217
49. Xiao F., Arnold T., Zhang S., et al. Matrix metalloproteinases are not involved in early brain edema formation after cardiac arrest in rats. Acta Neurochir Suppl 86 (2003) 75-78
50. Cho J.Y., Kim I.S., Jang Y.H., Kim A.R., and Lee S.R. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci Lett 404 (2006) 330-335
51. Rivera S., Ogier C., Jourquin J., et al. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 15 (2005) 19-32
52. Lee S.R., Tsuji K., and Lo E.H. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24 (2004) 671-678
53. Rubbo H., Darley-Usmar V., and Freeman B.A. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 9 (1996) 809-820
54. Rork T.H., Hadzimichalis N.M., Kappil M.A., and Merrill G.F. Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium. J Mol Cell Cardiol 40 (2006) 553-561
55. Giraudon P., Buart S., Bernard A., and Belin M.F. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes. Mol Psychiatry 2 (1997) 107-110
56. Weston R.M., Jones N.M., Jarrott B., and Callaway J.K. Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 27 (2006) 100-114
57. Bhat N.R., Zhang P., Lee J.C., and Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18 (1998) 1633-1641
58. Giulian D., and Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 12 (1993) I84-I90
59. Dijkstra U., Gabreels F., Joosten E., et al. Friedreich's ataxia: intravenous pyruvate load to demonstrate a defect in pyruvate metabolism. Neurology 34 (1984) 1493-1497
60. Olivencia-Yurvati A.H., Blair J.L., Baig M., and Mallet R.T. Pyruvate-enhanced cardioprotection during surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 715-720
61. Abe K., Aoki M., Kawagoe J., et al. Ischemic delayed neuronal death: a mitochondrial hypothesis. Stroke 8 (1995) 1478-1489